Uredepa

This classification denotes an ethylenimine compound with the molecular formula C7H14N3O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9V30JZ75AB, chemically known as carbamic acid, (bis(1-aziridinyl)phosphinyl)-, ethyl ester but more generally known as uredepa, which bears US NIH Compound Identifier 9332. European Medicines Agency schedules Uredepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11385MIG. The term UREDEPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). UREDEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule uredepa under HS 29339990 and SITC 51577. As of Q4 2014, UREDEPA remains US FDA's Preferred Term for this commodity. Uredepa bears US NLM identifiers UMLS ID C1519821 and NCI Concept Code C2072. SMILES: P(=O)(N1CC1)(N1CC1)NC(=O)OCC.